Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 18.104.22.168) - Histone deacetylase 2 is an enzyme encoded by the HDAC2 gene. It plays an important role in transcriptional regulation, cell cycle progression and developmental events.
Histone deacetylases act via the formation of large multiprotein complexes. It forms transcriptional repressor complexes by associating with MAD, SIN3, YY1 and N-COR.
It interacts in the late S-phase of DNA-replication with DNMT1 in the other transcriptional repressor complex composed of DNMT1, DMAP1, PCNA, and CAF1. It deacetylates TSHZ3 and regulates its transcriptional repressor activity.
Report Source: www.themarketreports.com/report/hi…e-review-h1-2018
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Histone Deacetylase 2 targeted therapeutics and enlists all their major and minor projects
- The report assesses Histone Deacetylase 2 targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Histone Deacetylase 2 targeted therapeutics
Report available at: www.themarketreports.com/report/buy-now/1022571
- 4SC AG
- AlfaSigma SpA
- Celgene Corp
- Chipscreen Biosciences Ltd
- Curis Inc
- HitGen LTD
- Italfarmaco SpA
- Medivir AB
- MEI Pharma Inc
- Merck & Co Inc
- Yungjin Pharm Co Ltd
- Zhejiang Hisun Pharmaceutical Co Ltd
Got a question; ask us at: www.themarketreports.com/report/as…ur-query/1022571
Category: Market Research Publishers and RetailersCompany about: The Market Reports aims to provide the best industry and market reports to a seeker. We are looking forward to a place where we are the one stop destination for all the report seekers irrespective of any country, category, domain, etc. We are always open on call and email (24*7) to your queries and very clean with the business methodology. Since we are dealing with so many Publishers, we can actually give you what suits best in accordance to your requirements.
For more information: